ev3 stent gets FDA, CE stent nods for Protege

Interventional device firm ev3 of Plymouth, MN, has received Food and Drug Administration 510(k) clearance to market its Protege EverFlex self-expanding stent system for the palliative treatment of malignant neoplasms in the biliary tree.

Additionally, ev3 obtained CE Mark approval for the product for general use in the peripheral vasculature, including common and external iliac, subclavian, and superficial femoral arteries, the company said.

By AuntMinnie.com staff writers
March 10, 2006

Related Reading

ev3 stent gets 510(k), October 21, 2004

Copyright © 2006 AuntMinnie.com

Page 1 of 181
Next Page